Chloé Pasin

Chloé Pasin

Universität Zürich

H-index: 11

Europe-Switzerland

About Chloé Pasin

Chloé Pasin, With an exceptional h-index of 11 and a recent h-index of 11 (since 2020), a distinguished researcher at Universität Zürich, specializes in the field of quantitative immunology, biostatistics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study

Patient and Public Involvement in HIV research: a mapping review and development of an online evidence map

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection

Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID‐19 prevention

Factors associated with uptake of cervical cancer screening among women in the Swiss HIV Cohort Study

Seroprofiling of antibodies against endemic human coronaviruses and severe acute respiratory syndrome coronavirus 2 in a human immunodeficiency virus cohort in Lesotho …

Parameter estimation in nonlinear mixed effect models based on ordinary differential equations: an optimal control approach

Assessing immunogenicity barriers of the HIV-1 envelope trimer

Chloé Pasin Information

University

Position

___

Citations(all)

668

Citations(since 2020)

620

Cited By

125

hIndex(all)

11

hIndex(since 2020)

11

i10Index(all)

13

i10Index(since 2020)

12

Email

University Profile Page

Google Scholar

Chloé Pasin Skills & Research Interests

quantitative immunology

biostatistics

Top articles of Chloé Pasin

Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study

The Journal of Infectious Diseases

2024/1/16

Patient and Public Involvement in HIV research: a mapping review and development of an online evidence map

2024/3/13

David Jackson-Perry
David Jackson-Perry

H-Index: 2

Chloé Pasin
Chloé Pasin

H-Index: 5

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection

Mbio

2024/2/14

Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID‐19 prevention

British Journal of Haematology

2024/2/7

Chloé Pasin
Chloé Pasin

H-Index: 5

Factors associated with uptake of cervical cancer screening among women in the Swiss HIV Cohort Study

screening

2016

Seroprofiling of antibodies against endemic human coronaviruses and severe acute respiratory syndrome coronavirus 2 in a human immunodeficiency virus cohort in Lesotho …

The Journal of Infectious Diseases

2023/10/15

Parameter estimation in nonlinear mixed effect models based on ordinary differential equations: an optimal control approach

Computational Statistics

2023/10/14

Chloé Pasin
Chloé Pasin

H-Index: 5

Rodolphe Thiébaut
Rodolphe Thiébaut

H-Index: 45

Assessing immunogenicity barriers of the HIV-1 envelope trimer

NPJ vaccines

2023/9/30

Sex and gender in infection and immunity: addressing the bottlenecks from basic science to public health and clinical applications

Royal Society Open Science

2023/7/5

Chloé Pasin
Chloé Pasin

H-Index: 5

Melanie Schirmer
Melanie Schirmer

H-Index: 23

Respiratory Disease Factors Link with Reduced SARS-CoV-2 Susceptibility in People with HIV

2023/5/23

Antibody response to a third SARS‐CoV‐2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation

British Journal of Haematology

2023/4

Quantifying and predicting ongoing human immunodeficiency virus type 1 transmission dynamics in Switzerland using a distance-based clustering approach

The Journal of Infectious Diseases

2023/2/15

DELINEATING FACTORS ASSOCIATED WITH ASYMPTOMATIC PRIMARY SARS-CoV-2 INFECTION

Topics in Antiviral Medicine

2023

Delineating the effect of sex hormone intake on immunity in cis and trans women with HIV

medRxiv

2023

Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV

Aids

2022/8/1

Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response

The Journal of Clinical Investigation

2022/6/15

CHARACTERIZATION AND DETERMINANTS OF LONG-TERM IMMUNE RECOVERY UNDER SUPPRESSIVE ANTIRETROVIRAL THERAPY

JAIDS Journal of Acquired Immune Deficiency Syndromes

2022/5/13

Antibody response to SARS-CoV-2 vaccination in patients following allogeneic hematopoietic cell transplantation

Vaccines

2023/12/1

Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation

2022

Efficacy of a third Dose of SARS-CoV-2 Vaccine in allogeneic Stem Cell Transplant Recipients and healthy Controls

Oncology Research and Treatment

2022

See List of Professors in Chloé Pasin University(Universität Zürich)